Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours
16 Oct 2024
Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours
Selecting patients wisely for neoadjuvant therapy in HPB cancers
Assessment of suicide risk in cancer patients
Cancer journeys: Research from India
Depression in cancer
Managing 'fear of recurrence' of cancer patients
Psychological issues in familial cancer
Pancreatic, hepatic and biliary malignancies
Administering systemic chemotherapy improves survival for patients with resectable CRCLM